The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse.

Yawen WangJiadai XuBei XuPanpan LiYang YangWenjing WangTianhong XuAziguli MaihemaitiTianwei LanPu WangLiang RenChi ZhouXianmuseye AihemaitiPeng Liu

Published in: Cancer (2023)

In the setting of novel therapy, 1q gain/amp still acts as an independent adverse prognostic factor. Patients with 1q gain/amp achieved VGPR rapidly but had inferior survival.

Keyphrases

prognostic factors
newly diagnosed
protein kinase
multiple myeloma
emergency department
free survival
electronic health record